FSTLX
Price
$34.55
Change
+$0.14 (+0.41%)
Updated
Oct 17 closing price
Net Assets
1.94B
VIVIX
Price
$72.41
Change
+$0.36 (+0.50%)
Updated
Oct 17 closing price
Net Assets
207.8B
Interact to see
Advertisement

FSTLX vs VIVIX

Header iconFSTLX vs VIVIX Comparison
Open Charts FSTLX vs VIVIXBanner chart's image
Federated Hermes MDT Large Cap Value R6
Price$34.55
Change+$0.14 (+0.41%)
VolumeN/A
Net Assets1.94B
Vanguard Value Index I
Price$72.41
Change+$0.36 (+0.50%)
VolumeN/A
Net Assets207.8B
FSTLX vs VIVIX Comparison Chart in %
View a ticker or compare two or three
VS
FSTLX vs. VIVIX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSTLX is a StrongBuy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 208B vs. FSTLX (1.94B). VIVIX pays higher dividends than FSTLX: VIVIX (2.09) vs FSTLX (1.06). FSTLX was incepted earlier than VIVIX: FSTLX (9 years) vs VIVIX (27 years). FSTLX (0.85) is less costly to investors than VIVIX (0.04). FSTLX is a more actively managed with annual turnover of: 69.00 vs. VIVIX (9.00). FSTLX has a lower initial minimum investment than VIVIX: FSTLX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 4.12 vs. FSTLX (-2.83). VIVIX return over 5 years is better than : 70.92 vs. FSTLX (39.29).
FSTLXVIVIXFSTLX / VIVIX
Total Expense Ratio0.700.041,750%
Annual Report Gross Expense Ratio0.850.042,125%
Fund Existence9 years27 years-
Gain YTD12.4579.202135%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.94B208B1%
Annual Yield % from dividends1.062.0950%
Returns for 1 year-2.834.12-69%
Returns for 3 years30.0542.2771%
Returns for 5 years39.2970.9255%
Returns for 10 yearsN/A128.26-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLYYF0.41N/A
N/A
Celyad Oncology SA
FGROF2.75N/A
N/A
Firstgroup PLC
JFEEF12.04N/A
N/A
JFE Holdings Inc.
CIXPF9.91-0.18
-1.78%
Caixabank SA
QUEXF0.65-0.06
-8.45%
Q2 METALS CORP